An innovative CRISPR-Cas12f-based activator system may hold significant potential in the future of gene therapy and biological research, suggest researchers of a new study. The study highlights the ...
To help achieve more precise control of gene therapy, engineers have designed a new control circuit that can keep gene expression levels within a target range. The method could be used to deliver ...
Fig. 4: Typical UHPLC-MRM/MS chromatograms of tryptic peptides for quantification of hFXN-M (4.8 ng/mg tissue) from a control (non-FRDA) human heart and mFXN-M (1.9 ng/mg tissue) from a control Resus ...
Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...
A major limitation to developing chimeric antigen receptor (CAR)-T cell therapies for solid tumors is identifying surface proteins highly expressed in tumors but not in normal tissues. Here, we ...
Scientists at the MRC Laboratory of Medical Sciences (LMS) have discovered a DNA-based “dimmer switch” that regulates the activity of a critical developmental gene, Cdx2. This work could pave the way ...
In a recent study published in the journal Nature Biotechnology, researchers describe the pA regulator system based on a ribonucleic acid (RNA)-based switch to regulate mammalian gene expression by ...
Contemporary AD systemic selection remains largely preference- and logistics-driven, despite modest EASI-75/EASI-90 response rates with Th2 biologics and JAK inhibitors at 12–16 weeks. The GEP-497 ...
Dual Designations Affirm Significant Unmet Need; Multi-Year Phase 1 Data Published in the New England Journal of Medicine Underpin Advancement to Phase 2 ATLANTA, April 29, 2026 /PRNewswire/ -- ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results